Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J DiGirolamo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Osteoporosis Reports|March 18, 2014
Therapies for musculoskeletal disease: can we treat two birds with one stone?Christian M Girgis, Nancy Mokbel, Douglas J Digirolamo
Nature Reviews. Rheumatology|October 10, 2012
The skeleton as an endocrine organDouglas J DiGirolamo, Thomas L Clemens, Stavroula Kousteni
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 2013
Bone and skeletal muscle: neighbors with close tiesDouglas J DiGirolamo, Douglas P Kiel, Karyn A Esser
Tissue Engineering. Part B, Reviews|April 13, 2017
Biophysical Stimulation for Engineering Functional Skeletal MuscleSarah M Somers, Alexander A Spector, Douglas J DiGirolamo, et al.
Bone Research|August 15, 2015
Nrf2 is required for normal postnatal bone acquisition in miceJung-Hyun Kim, Vandana Singhal, Shyam Biswal, et al.
Bone Research|August 15, 2015
Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal PhenotypesVandana Singhal, Brian C Goh, Mary L Bouxsein, et al.
Bone Research|July 11, 2015
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfectaDouglas J DiGirolamo, Vandana Singhal, Xiaoli Chang, et al.
The Journal of Biological Chemistry|June 8, 2007
Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and actionKeertik Fulzele, Douglas J DiGirolamo, Zhongyu Liu, et al.
The Journal of Biological Chemistry|August 19, 2007
Mode of growth hormone action in osteoblastsDouglas J DiGirolamo, Aditi Mukherjee, Keertik Fulzele, et al.
Breast Cancer Research : BCR|September 20, 2005
Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatmentMonica M Richert, Pushkar A Phadke, Gail Matters, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Osteoporosis Reports|March 18, 2014
Therapies for musculoskeletal disease: can we treat two birds with one stone?Christian M Girgis, Nancy Mokbel, Douglas J Digirolamo
Nature Reviews. Rheumatology|October 10, 2012
The skeleton as an endocrine organDouglas J DiGirolamo, Thomas L Clemens, Stavroula Kousteni
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 2013
Bone and skeletal muscle: neighbors with close tiesDouglas J DiGirolamo, Douglas P Kiel, Karyn A Esser
Tissue Engineering. Part B, Reviews|April 13, 2017
Biophysical Stimulation for Engineering Functional Skeletal MuscleSarah M Somers, Alexander A Spector, Douglas J DiGirolamo, et al.
Bone Research|August 15, 2015
Nrf2 is required for normal postnatal bone acquisition in miceJung-Hyun Kim, Vandana Singhal, Shyam Biswal, et al.
Bone Research|August 15, 2015
Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal PhenotypesVandana Singhal, Brian C Goh, Mary L Bouxsein, et al.
Bone Research|July 11, 2015
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfectaDouglas J DiGirolamo, Vandana Singhal, Xiaoli Chang, et al.
The Journal of Biological Chemistry|June 8, 2007
Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and actionKeertik Fulzele, Douglas J DiGirolamo, Zhongyu Liu, et al.
The Journal of Biological Chemistry|August 19, 2007
Mode of growth hormone action in osteoblastsDouglas J DiGirolamo, Aditi Mukherjee, Keertik Fulzele, et al.
Breast Cancer Research : BCR|September 20, 2005
Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatmentMonica M Richert, Pushkar A Phadke, Gail Matters, et al.
Pageof 2